SDGRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Schrodinger, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$23.12+0.52 (+2.30%)
Close on Oct 19, 2026
- Market cap
- $1.75B
- P/E (TTM)
- –
- Dividend yield
- –
Schrodinger, Inc. revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Software | $199.50M | $180.37M | $159.12M | $135.58M | $113.24M | $92.53M | $66.74M | 78.0% | +10.6% |
| Drug Discovery | $56.37M | $27.17M | $57.54M | $45.38M | $24.70M | $15.57M | $18.81M | 22.0% | +107.4% |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Software products and services | $199.50M | $180.37M | $159.12M | $135.58M | $113.24M | $92.53M | $66.74M | 78.0% | +10.6% |
| Revenue from contracts with customers | $183.51M | $172.35M | $157.32M | $134.58M | $112.24M | $91.53M | $66.74M | 71.7% | +6.5% |
| On-premise software | $101.45M | $104.02M | $104.51M | $84.49M | $74.60M | $58.31M | $42.65M | 39.6% | -2.5% |
| Drug discovery | $56.37M | $27.17M | $57.54M | $45.38M | $24.70M | $15.57M | $18.81M | 22.0% | +107.4% |
| Software contribution | $54.76M | $25.14M | $54.72M | $43.43M | – | – | – | 21.4% | +117.8% |
| Hosted software | $45.12M | $35.25M | $20.38M | $14.89M | $11.08M | $9.19M | $7.42M | 17.6% | +28.0% |
| Software maintenance | $27.29M | $23.28M | $23.07M | $20.00M | $17.29M | $14.47M | $11.64M | 10.7% | +17.2% |
| Professional services | $9.65M | $9.80M | $9.37M | $15.21M | $9.27M | $9.56M | $5.03M | 3.8% | -1.5% |
| Revenue from contracts with customers | – | – | – | – | – | $91.53M | $66.74M | – | – |
| Contribution | – | – | – | – | – | $1.00M | – | – | – |
| Software contribution | – | – | $1.80M | $1.00M | $1.00M | $1.00M | – | – | – |
| Drug discovery services revenue from contracts with customers | – | – | – | $43.43M | $24.58M | $15.57M | – | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| United States | $152.96M | $114.87M | $161.96M | $123.56M | $90.40M | $60.74M | $47.62M | 59.8% | +33.2% |
| APAC | $75.16M | $65.65M | $29.14M | $34.45M | $28.88M | – | – | 29.4% | +14.5% |
| EMEA | $26.18M | $25.80M | $24.57M | $21.68M | $17.78M | – | – | 10.2% | +1.5% |
| Rest of World | $1.56M | $1.22M | $1.00M | $1.27M | $875.00K | $8.43M | $6.05M | 0.6% | +28.2% |
| Europe | – | – | – | $33.05M | $27.81M | $24.37M | $17.50M | – | – |
| Japan | – | – | – | $10.47M | $8.57M | $14.56M | $14.37M | – | – |
From the segment and revenue-disaggregation notes of Schrodinger's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.